Peer Review: KSQ woos Beni Wolf from Blueprint with CRISPR platform; AstraZeneca exec jumps to CNS biotech spun out of Takeda
→ After four years at Blueprint Medicines, Beni Wolf is hopping over to Cambridge, Massachusetts-based KSQ Therapeutics as chief medical officer, as it prepares to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
